Tag Archives: RAPT Therapeutics Inc.

Biotech IPO scene shifts into pre-holiday slow gear, but several former IPOs are soaring with analysts saying Buy, Buy, Buy!

IPO Sector: US tech IPOs have mostly vanished in the fourth quarter following disappointments from multiple fast-growing, unprofitable unicorns. Healthcare (55% of 4Q IPOs) and Chinese issuers (24%) have hogged… Read more »

More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.

Three companies priced in New York last week–two biotechs and Chinese online real estate marketplace Shenzhen Fangdd Network Technology Co Ltd. (Nasdaq:DUO). The China-USA, free-floating trade anxieties aren’t dissuading the… Read more »

Fasten your seatbelts, investors: Chinese health sector IPOs creeping onto Nasdaq in bigger numbers.

In a wild week of health-sector action in the IPO arena, three more Chinese funding seekers eschewed the Shanghai and Hong Kong markets, favoring the more robust Nasdaq the week… Read more »

Pace of health-sector IPO action finally slows, but deal sizes grow, proving lots of cash still parked on the sidelines.

Three tech companies in the health sector entered the public market last week, raising a total of $601 million. Here are the proud IPOs and a glance at this week’s… Read more »

July’s IPO action in health sector foreshadows record month of pricings.

The second week of July continued the stampede among healthcare startups and seasoned players in search of new funding from Wall Street and, in one case, the Hong Kong exchange…. Read more »